Skip to content

Topography Guided LASIK by Different Protocols for Treatment of Astigmatism

Comparison of the Outcome of Topography Modified Refraction Correction to Standard Clinical Refraction Correction in Myopic Astigmatic Topography-guided LASIK

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03597906
Enrollment
30
Registered
2018-07-24
Start date
2018-08-15
Completion date
2020-01-20
Last updated
2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractive Surgery

Keywords

Topography guided ablation, Astigmatism, LASIK

Brief summary

Background and Rationale: LASIK has been among the highest satisfaction rates of surgical procedures, ranging from 82%-98%. Different ablation profiles have been developed over the years. The purpose of this study is to validate this novel measurement by comparing the visual outcomes when the TMR is used in myopic astigmatic LASIK to using the standard manifest refraction or the Topolyzer measurements alone. Objectives : To evaluate the safety, efficacy and predictability of topography-guided myopic LASIK with three different refraction treatment strategies.

Detailed description

Candidates for refractive surgery above 18 years with myopic astigmatism and no previous ocular surgery. Sample size 60 eyes. surgery: * 60 eyes of myopic topography-guided LASIK procedures with the same refractive platform (FS200 femtosecond to create a flap between90: 110 μm with diameter 8:9 mm and EX500 excimer lasers) will be randomized for treatment as follows: * Group A: 20 eyes will be treated using Contoura vision with the standard manifest refraction. * Group B: 20 eyes will be treated with Contoura vision using the topographic astigmatic power and axis and without change in the spherical power (using the same spherical power as the manifest refraction). * Group C \[TMR\]: 20 eyes will be treated with Contoura vision using the topographic astigmatic power and axis and modifying the spherical power to obtain the same spherical equivalent as the manifest refraction. This is done by subtracting half of the difference between topographic astigmatic power and the manifest astigmatic power from the spherical power (topography-modified treatment refraction). * The standard postoperative treatment is combined steroids and antibiotics eye drops 5 times daily for one week ,then three times daily for three days and lubricant eye drops 5 times daily for six months. Postoperatively, the patients will be examined at 1 week, 1 month and 3 months. All postoperative follow-up visits included measurement of UDVA, CDVA (if indicated) and refraction, besides full ophthalmological examination and performing pentacam and topolyzer after 3 months

Interventions

PROCEDUREtopography guided ablation

using the data obtained from the topolyzer for correction of refractive errors specially astigmatism we use 3 different treatment protocols

using for ablation the exact manifest refraction

PROCEDUREfull topography modified refraction

full topography modified refraction means changing both sphere and cylinder power in the ablation profile

PROCEDUREpartial topography modified refraction

partial topography modified refraction means changing only cylinder power and axis in the ablation profile

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

A prospective, randomized and comparative interventional study

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Stable refractive error: Myopic astigmatism ≥ -1.5 D * Valid Topolyzer maps (at least four out of eight right maps with green analyzed area and the registration box is green).

Exclusion criteria

1. Estimated postoperative residual stromal bed thickness of less than 300µm. 2. Glaucomatous patients. 3. Patients with keratoconus. 4. Patients with pervious refractive surgery. 5. History of previous ocular trauma or surgery. 6. History of recent herpetic ulcer or viral keratitis. 7. Basement membrane disease, history of recurrent corneal erosions. 8. Sicca syndrome, dry eye.

Design outcomes

Primary

MeasureTime frameDescription
post operative residual astigmatism3 monthsmeasuring the post operative residual astigmatism and comparison between the 3 group to reach to the most accurate protocol.

Secondary

MeasureTime frameDescription
measurement of the postoperative unaided visual acuity3 monthsmeasurement of the postoperative unaided visual acuity and comparison between the 3 group to reach to the most accurate protocol.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026